1Lansky, EP & Newman, RA (2007) Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 109, 177–206.
2Basu, A & Penugonda, K (2009) Pomegranate juice: a heart-healthy fruit juice. Nutr Rev 67, 49–56.
3Adams, LS, Seeram, NP, Aggarwal, BB, et al. (2006) Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem 54, 980–985.
4Jung, KH, Kim, MJ, Ha, E, et al. (2006) Suppressive effect of Punica granatum on the production of tumor necrosis factor (Tnf) in BV2 microglial cells. Biol Pharm Bull 29, 1258–1261.
5Romier-Crouzet, B, Van De, WJ, During, A, et al. (2009) Inhibition of inflammatory mediators by polyphenolic plant extracts in human intestinal Caco-2 cells. Food Chem Toxicol 47, 1221–1230.
6Seeram, NP, Henning, SM, Zhang, Y, et al. (2006) Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr 136, 2481–2485.
7Shukla, M, Gupta, K, Rasheed, Z, et al. (2008) Bioavailable constituents/metabolites of pomegranate (Punica granatum L.) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro. J Inflamm (Lond) 5, 9.
8Kemperman, RA, Bolca, S, Roger, LC, et al. (2010) Novel approaches for analysing gut microbes and dietary polyphenols: challenges and opportunities. Microbiology 156, 3224–3231.
9Qin, J, Li, R, Raes, J, et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65.
10Selma, MV, Espin, JC & Tomas-Barberan, FA (2009) Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem 57, 6485–6501.
11Backhed, F & Crawford, PA (2010) Coordinated regulation of the metabolome and lipidome at the host-microbial interface. Biochim Biophys Acta 1801, 240–245.
12Ley, RE (2010) Obesity and the human microbiome. Curr Opin Gastroenterol 26, 5–11.
13Caesar, R, Fak, F & Backhed, F (2010) Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 268, 320–328.
14Diamant, M, Blaak, EE & de Vos, WM (2010) Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 12, 272–281.
15Geurts, L, Lazarevic, V, Derrien, M, et al. (2011) Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol 2, 149.
16Delzenne, NM, Neyrinck, AM & Cani, PD (2011) Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact 10, S10.
17Delzenne, NM, Neyrinck, AM, Backhed, F, et al. (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7, 639–646.
18Everard, A, Lazarevic, V, Derrien, M, et al. (2011) Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60, 2775–2786.
19Neyrinck, AM, Possemiers, S, Verstraete, W, et al. (2012) Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. J Nutr Biochem 23, 51–59.
20Nishikawa, S, Sugimoto, J, Okada, M, et al. (2012) Gene expression in livers of BALB/C and C57BL/6J mice fed a high-fat diet. Toxicol Pathol 40, 71–82.
21Watanabe, H, Numata, K, Ito, T, et al. (2004) Innate immune response in Th1- and Th2-dominant mouse strains. Shock 22, 460–466.
22Abdul-Ghani, MA, Matsuda, M, Balas, B, et al. (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30, 89–94.
23Neyrinck, AM, Bindels, LB, De, BF, et al. (2009) Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. Int Immunopharmacol 9, 767–773.
24Friedewald, WT, Levy, RI & Fredrickson, DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502.
25Aggarwal, BB & Shishodia, S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71, 1397–1421.
26Afaq, F, Saleem, M, Krueger, CG, et al. (2005) Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int J Cancer 113, 423–433.
27Ahmed, S, Wang, N, Hafeez, BB, et al. (2005) Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro. J Nutr 135, 2096–2102.
28Hayden, MS & Ghosh, S (2004) Signaling to NF-kappaB. Genes Dev 18, 2195–2224.
29Schieven, GL (2005) The biology of p38 kinase: a central role in inflammation. Curr Top Med Chem 5, 921–928.
30Hsieh, PS, Jin, JS, Chiang, CF, et al. (2009) COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity (Silver Spring) 17, 1150–1157.
31Cerda, B, Llorach, R, Ceron, JJ, et al. (2003) Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur J Nutr 42, 18–28.
32Crozier, A, Del, RD & Clifford, MN (2010) Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 31, 446–467.
33Larrosa, M, Garcia-Conesa, MT, Espin, JC, et al. (2010) Ellagitannins, ellagic acid and vascular health. Mol Aspects Med 31, 513–539.
34Espin, JC, Gonzalez-Barrio, R, Cerda, B, et al. (2007) Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. J Agric Food Chem 55, 10476–10485.
35Stoffel, M, Espinosa, R III, Le Beau, MM, et al. (1993) Human glucagon-like peptide-1 receptor gene. Localization to chromosome band 6p21 by fluorescence in situ hybridization and linkage of a highly polymorphic simple tandem repeat DNA polymorphism to other markers on chromosome 6. Diabetes 42, 1215–1218.
36Gonzalez-Sarrias, A, Larrosa, M, Tomas-Barberan, FA, et al. (2010) NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br J Nutr 104, 503–512.
37Gonzalez-Sarrias, A, Espin, JC, Tomas-Barberan, FA, et al. (2009) Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins. Mol Nutr Food Res 53, 686–698.
38Parkar, SG, Stevenson, DE & Skinner, MA (2008) The potential influence of fruit polyphenols on colonic microflora and human gut health. Int J Food Microbiol 124, 295–298.
39Tzounis, X, Vulevic, J, Kuhnle, GG, et al. (2008) Flavanol monomer-induced changes to the human faecal microflora. Br J Nutr 99, 782–792.
40Roberfroid, M, Gibson, GR, Hoyles, L, et al. (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104, Suppl. 2, S1–S63.
41Delzenne, NM & Cani, PD (2011) Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr 31, 15–31.
42Cani, PD, Neyrinck, AM, Fava, F, et al. (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374–2383.
43Bialonska, D, Ramnani, P, Kasimsetty, SG, et al. (2010) The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. Int J Food Microbiol 140, 175–182.
44Martinez, I, Wallace, G, Zhang, C, et al. (2009) Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Appl Environ Microbiol 75, 4175–4184.
45Neyrinck, AM, Possemiers, S, Druart, C, et al. (2011) Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS One 6, e20944.
46Ridlon, JM, Kang, DJ & Hylemon, PB (2006) Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47, 241–259.